Download PDF
kleintier konkret 2020; 23(03): 36-47
DOI: 10.1055/a-1089-3746
Innere Medizin

NSAID-Nebenwirkungen bei Hund und Katze – Wie häufig und was tun?

Lydia Kuhnert
,
Romy M. Heilmann
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Falsch angewendet können NSAID mit erheblichen, zum Teil lebensbedrohlichen Nebenwirkungen einhergehen. Der Beitrag informiert über pharmakologische Hintergründe, typische Nebenwirkungen und die therapeutische Versorgung im Falle einer Intoxikation.

Publication History

Article published online:
23 June 2020

Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 McLean MK, Khan SA. Toxicology of frequently encountered nonsteroidal anti-inflammatory drugs in dogs and cats: an update. Vet Clin North Am Small Anim Pract 2018; 48 (06) 969-984
    CrossrefPubMedGoogle Scholar
  • 2 Potter M, Macintire DK. NSAID toxicity in dogs. Comp Small Anim Pract 2008; 10 (10) 8-12
    Google Scholar
  • 3 Knapp DW, Glickman NW, Widmer WR. et al. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemother Pharmacol 2000; 46 (03) 221-226
    CrossrefPubMedGoogle Scholar
  • 4 Saito T, Tamura D, Asano R. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors. Oncol Rep 2014; 31 (04) 1637-1644
    CrossrefPubMedGoogle Scholar
  • 5 Narita T, Sato R, Motoishi K. et al. The interaction between orally administered non-steroidal anti-inflammatory drugs and prednisolone in healthy dogs. J Vet Med Sci 2007; 69 (04) 353-363
    CrossrefPubMedGoogle Scholar
  • 6 Lascelles BD, Blikslager AT, Fox SM. et al. Gastrointestinal tract perforation in dogs treated with a selective cyclooxygenase-2 inhibitor: 29 cases (2002–2003). J Am Vet Med Assoc 2005; 227 (07) 1112-1117
    CrossrefPubMedGoogle Scholar
  • 7 Veterinärmedizinischer Informationsdienst für Arzneimittelanwendung, Toxikologie und Arzneimittelrecht. Im Internet (Stand: November 2019): http://www.vetidata.de
    Google Scholar
  • 8 Löscher W, Richter A, Potschka H. Hrsg. Pharmakotherapie bei Haus- und Nutztieren. 9. Aufl.. Stuttgart: Enke; 2014
    Google Scholar
  • 9 Hsu WH. Handbook of Veterinary Pharmacology. 2nd ed. Arnes: Wiley; 2013
    Google Scholar
  • 10 Mealey KL. Pharmacotherapeutics for Veterinary Dispensing. Hoboken: Wiley Blackwell; 2019
    Google Scholar
  • 11 Gupta RC. Veterinary Toxicology: Basic and Clinical Principles. 3rd ed. Amsterdam: Academic Press; 2018
    Google Scholar
  • 12 Fritzenschaft N. Unerwünschte Arzneimittelwirkungen selektiver Cyclooxygenase-2-Hemmstoffe bei Hund und Katze [Dissertation]. München: Ludwig-Maximilians-Universität München; 2017
    PubMedGoogle Scholar
  • 13 Jasiecka-Mikolajczyk A, Maślanka T, Jaroszewkski JJ. Pharmacological characteristics of metamizole. Pol J Vet Sci 2014; 17 (01) 207-214
    CrossrefPubMedGoogle Scholar
  • 14 Wooten JG, Blikslager AT, Ryan KA. et al. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs. Am J Vet Res 2008; 69 (04) 457-464
    CrossrefPubMedGoogle Scholar
  • 15 Ng LE, Halliwell B, Wong KP. Nephrotoxic cell death by diclofenac and meloxicam. Biochem Biophys Res Commun 2008; 369 (03) 873-878
    CrossrefPubMedGoogle Scholar
  • 16 Mullins KB, Thomason JM, Lunsford KV. et al. Effects of carprofen, meloxicam and deracoxib on platelet function in dogs. Vet Anaesth Analg 2012; 39 (02) 206-217
    CrossrefPubMedGoogle Scholar
  • 17 Khan S, Andrews KL, Chin-Dusting JPF. Cyclo-oxygenase (COX) inhibitors and cardiovascular risk: are non-steroidal anti-inflammatory drugs really anti-inflammatory?. Int J Mol Sci 2019; 20 (17) 4262
    CrossrefPubMedGoogle Scholar
  • 18 Lees P, Pelligand L, Elliott J. et al. Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review. J Vet Pharmacol Ther 2015; 38 (01) 1-14
    PubMedGoogle Scholar
  • 19 Kongara K, Chambers JP. Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy. Vet Med (Auckl) 2018; 9: 53-61
    Google Scholar
  • 20 McFarland SE, Mischke RH, Hopster-Iversen C. et al. Systematic account of animal poisonings in Germany, 2012–2015. Vet Rec 2017; 180 (13) 327
    CrossrefPubMedGoogle Scholar
  • 21 Rostom A, Muir K, Dube C. et al. Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAID with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf 2009; 1: 47-71
    CrossrefPubMedGoogle Scholar
  • 22 Wallace JL, Syer S, Denou E. et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 2011; 141 (04) 1314-1322
    CrossrefPubMedGoogle Scholar
  • 23 Marks SL, Kook PH, Papich MG. et al. ACVIM concensus statement: support for rational administration of gastrointestinal protectants to dogs and cats. J Vet Intern Med 2018; 32 (06) 1823-1840
    CrossrefPubMedGoogle Scholar